| scholarly article | Q13442814 |
| P50 | author | David M. Holtzman | Q56827171 |
| Linda J Van Eldik | Q99563495 | ||
| P2093 | author name string | Reardon CA | |
| Cabana VG | |||
| Gilligan SM | |||
| LaDu MJ | |||
| Lukens JR | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| astrocyte | Q502961 | ||
| P1104 | number of pages | 12 | |
| P304 | page(s) | 2070-2081 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Nascent astrocyte particles differ from lipoproteins in CSF. | |
| P478 | volume | 70 |
| Q43732538 | A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release. |
| Q37119890 | Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation |
| Q39873829 | Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function |
| Q35152189 | An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia |
| Q38190156 | ApoE and Aβ in Alzheimer's disease: accidental encounters or partners? |
| Q34419653 | ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype |
| Q47281896 | Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid. |
| Q92322562 | Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies |
| Q39155261 | Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins |
| Q26858870 | Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease |
| Q37009967 | Apolipoprotein E and cholesterol in aging and disease in the brain |
| Q24604376 | Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy |
| Q38407177 | Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence |
| Q91779698 | Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation |
| Q48939701 | Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. |
| Q37846932 | Apolipoprotein E in Alzheimer's disease and other neurological disorders |
| Q42049013 | Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges |
| Q33532794 | Apolipoprotein-E forms dimers in human frontal cortex and hippocampus |
| Q37073034 | Arabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer's disease in vitro |
| Q41955387 | Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function |
| Q89841154 | Beyond the CNS: The many peripheral roles of APOE |
| Q38833309 | Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism |
| Q27314618 | Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease |
| Q40903084 | Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo |
| Q33363912 | Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele |
| Q36501289 | Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis |
| Q37926912 | Cholesterol metabolism in Huntington disease |
| Q36355194 | Cholesterol: its regulation and role in central nervous system disorders |
| Q28504767 | Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease |
| Q37731946 | Diet and age interactions with regards to cholesterol regulation and brain pathogenesis |
| Q38776867 | Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures |
| Q38733357 | EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease. |
| Q48146086 | Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid. |
| Q40849918 | Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease |
| Q24685843 | Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain |
| Q41815057 | Functional and structural properties of lipid-associated apolipoprotein J (clusterin). |
| Q42816432 | Generation and function of astroglial lipoproteins from Niemann-Pick type C1-deficient mice |
| Q34488287 | Glia and neurodevelopment: focus on fetal alcohol spectrum disorders |
| Q48477194 | Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. |
| Q37487871 | Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation |
| Q26996502 | HDL and glucose metabolism: current evidence and therapeutic potential |
| Q33861622 | HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease |
| Q45993868 | Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. |
| Q49129166 | Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules |
| Q46262337 | Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels |
| Q35794586 | In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q37416809 | Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis |
| Q28508278 | Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E |
| Q33945108 | LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice |
| Q28595076 | LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins |
| Q40879124 | Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides |
| Q42323859 | Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism |
| Q39948292 | Lysosulfatide regulates the motility of a neural precursor cell line via calcium-mediated process collapse |
| Q34730744 | Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture |
| Q90736527 | O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain |
| Q36383616 | Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. |
| Q35087794 | Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition |
| Q44722698 | Oxidized lipoproteins, beta amyloid peptides and Alzheimer's disease |
| Q28582464 | Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift |
| Q36807556 | Prenatal Ethanol Exposure Up-Regulates the Cholesterol Transporters ATP-Binding Cassette A1 and G1 and Reduces Cholesterol Levels in the Developing Rat Brain |
| Q37752606 | Proposed mechanism for lipoprotein remodelling in the brain. |
| Q33245094 | Protein arginylation in rat brain cytosol: a proteomic analysis |
| Q39495324 | Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist |
| Q33609376 | Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease |
| Q24633831 | Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies |
| Q37518162 | Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator-and apolipoprotein E-conjugated liposomes to the hippocampus |
| Q35188178 | Retinoic acid isomers up-regulate ATP binding cassette A1 and G1 and cholesterol efflux in rat astrocytes: implications for their therapeutic and teratogenic effects |
| Q34509759 | Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy |
| Q40332420 | Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein |
| Q37369508 | Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation |
| Q38175420 | Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk |
| Q40928015 | Studies on the cytosolic phospholipase A2 in immortalized astrocytes (DITNC) revealed new properties of the calcium ionophore, A23187. |
| Q35793178 | The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. |
| Q35096114 | The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol |
| Q50134122 | The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis |
| Q24803005 | beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins |
| Q47630370 | α-Synuclein Regulates Neuronal Cholesterol Efflux. |
Search more.